Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Colchicine on the Clinical Outcome of COVID-19 and the Development of Post-COVID-19 Pulmonary Fibrosis: Randomized Controlled Clinical Trial

NCT04818489 is registered in ClinicalTrials.gov with ClinAmygate as lead sponsor.

NCT NCT04818489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Colchicine on the Clinical Outcome of COVID-19 and the Development of Post-COVID-19 Pulmonary Fibrosis: Randomized Controlled Clinical Trial
Lead sponsor
ClinAmygate
Phase
Phase 4
Overall status
Unknown status
Start date
March 25, 2021
Completion date
October 20, 2023
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, pulmonary fibrosis interstitial